The duplex telomere repeat (TTAGGG) n is an essential cis-acting element of the mammalian telomere, and an exogenous telomere repeat can induce chromosome breakage and de novo telomere formation at the site of a break (telomere seeding). Telomere seeding requires the telomere repeat (TTAGGG) n more stringently than does an in vitro telomerase assay, suggesting that it reflects the activity of a critical trans-acting element of the functional telomere, in addition to telomerase. Furthermore, telomere seeding is induced at a frequency fluctuating widely among human cell lines, suggesting variation in the activity of this hypothetical factor among cells. In this study, we investigated the cellular factor(s) required for telomere formation using the frequency of telomere seeding as an index and identified TRF1, one of the telomere repeat binding proteins, as an essential trans-acting factor. The exogenous telomere repeat induces telomere formation at a frequency determined by the availability of TRF1, even in telomerase-negative cells. Our study shows clearly that TRF1 has a novel physiological significance distinct from its role as a regulator of telomere length in the endogenous chromosome. The possible role of TRF1 in cell aging and immortalization is discussed.
INTRODUCTION
The telomere is an essential structure at each extremity of the chromosome and duplex repetitive DNA (TTAGGG) n [telomere repeat (TR)] has been identified as the most distal cis element of the telomere in vertebrate chromosomes (1, 2) . Although natural telomeric DNA consists of the TR and proximal subtelomeric DNA with unique repetitive sequences (3), the TR is considered to be the only functional cis element of vertebrate telomeres, for the following reasons. First, only the TR, but not the other subtelomeric repetitive DNA, is found at the human chromosome terminus created by natural DNA breakage (4, 5) . Secondly, the TR is the only cis element required for inducing chromosome breakage and de novo telomere formation at the site of the break in mammalian cells (telomere seeding) (6) .
The primary role of the TR is to ensure the replication of DNA at the chromosome terminus. During the proliferation of mammalian cells, the telomere shortens after every round of DNA replication, as DNA polymerase fails to synthesize the distal ends of chromosomal DNA ('end-replication problem') (7) . This problem is overcome by telomerase, an enzyme specialized for TR synthesis (8) . Another important role of the TR is to protect the chromosome termini from exposure to the cellular mechanism that detects and repairs DNA breakage ('DNA-damage checkpoint') (9) . A duplex loop structure found at the chromosome termini, called the t-loop, is thought to be required for this function (10) .
In addition to the functions described above, the TR is known to be a determinant of the lifespan of telomerasenegative somatic cells (telomere hypothesis of cell aging and immortalization) (11, 12) . Cell crisis is induced during the proliferation of primary cells when the TR becomes shorter than a critical length (1.5-2.0 kb) (11, 13) , whereas immortal cells can circumvent the crisis by stabilization of their telomeres (14) . Telomerase is considered to be a key player in this mechanism, for the following reasons. First, telomerase is frequently induced in the immortal cells that arise among senescent somatic cells (14) . Secondly, forced expression of telomerase by transgenesis can extend the lifespan of various somatic cells (15) , whereas the inhibition of telomerase activity by antisense RNA forces immortal HeLa cells into crisis (16) . Evidence is accumulating, however, to suggest the involvement of other trans-acting telomeric factors in cell aging and immortalization. For example, somatic cells derived from mice with no functional telomerase gene can be immortalized as efficiently as cells derived from normal mice (17, 18) . Furthermore, ∼30% of immortal human cells have no detectable telomerase activity (19, 20) .
Two TR-binding proteins (TRF1 and TRF2) have been identified as the trans-acting elements of telomere function in mammalian cells. Originally purified from HeLa cell extract as a duplex TR-binding factor (21) , TRF1 consists of 439 amino acid residues and is made up of three major functional domains: the N-terminal acidic domain, the dimerization domain and the C-terminal Myb-related DNA-binding domain (21) . TRF1 binds to TR as a homodimer, but with extreme spatial flexibility (22) (23) (24) . TRF2 is another TR-binding protein, identified by cDNA cloning based on homology to the Myb-related TR-binding domain of TRF1 (25, 26) . TRF2 consists of 500 amino acid resi-dues and has a domain structure similar to TRF1, except that the N-terminal domain of TRF2 is basic rather than acidic (25) . TRF2 also binds to TR as a homodimer (25) and is responsible for remodeling linear telomeric DNA into a t-loop (10) . The physiological functions of these TR-binding proteins have been investigated in cultured human cells (9, (27) (28) (29) . Consequently, TRF1 was identified as a negative regulator of the steady-state length of TR (27) and TRF2 as a capping factor protecting the chromosome termini from DNA damage checkpoint and from interchromosome fusion (9, 28) .
The function of the mammalian telomere has mainly been investigated by analyzing the structure and dynamics of endogenous telomeres in vivo, or by a biochemical approach using synthetic TRs and various cellular factors in vitro. Compared with these approaches, analyzing the function of synthetic TRs by their introduction into living mammalian cells is unique, because it allows us to investigate the function of TRs with definite structure, in relation to cellular factors under physiological condition. Exogenous DNA fragments containing the TR at the terminus (the 'telomere seed') have been shown to induce chromosome breakage and de novo telomere formation at the site of the break [telomere seeding (TS)] (30, 31) . The previous observation that the frequency of TS (the proportion of newly formed telomeres in the total integration events of the telomere seed) depends largely on the cell type examined (31) suggested that TS might reflect the intracellular environment related to telomere function. Hanish et al. (6) demonstrated subsequently that, in HeLa cells, TS is induced by telomeric repetitive DNA (TTAGGG) n , but not at all by other repetitive DNA [e.g. (TTAGGC) n or (TTGGGG) n ], whereas human telomerase recognized all of these sequences equally as substrates in vitro. Their results suggest that TS reflects the physiological function of the TR, as distinct from its role as a primer for telomerase. They also demonstrated that the strict sequence dependency observed in TS was identical to that observed in the interaction between TRF1 and DNA and therefore suggested that TRF1 was involved in de novo telomere formation (6) . Since their study, however, TRF2 has been identified as another TR-binding protein with a stringent sequence dependency in DNA binding, like TRF1 (25, 26) : both TRF1 and TRF2 bind duplex (TTAGGG) n , but cannot bind (TTAGGC) n , (TTGGGG) n , (TTAGGGGG) n or (TAGGG) n (25) . As this sequence dependency is identical with that observed in TS, TRF2 became another candidate molecule involved in telomere formation.
In this study, we investigated the trans-acting factor of human telomere formation by employing the frequency of TS as an index and identified TRF1 as a critical factor. Telomere formation was induced at an efficiency determined primarily by the availability of TRF1 in the cell, even in telomerase-negative cells. Based on these findings, the possible role of TRF1 in telomere function is discussed.
RESULTS

Cellular characteristics closely correlated with the efficiency of de novo telomere formation induced by an exogenous TR
The telomere seed used in this study consists of the following four functional parts: a synthetic vertebrate TR (TTAGGG) n of 0-2000 bp; a bacterial plasmid backbone derived from pUC19; yeast genes used in the construction of yeast artificial chromosomes (TRP1/ARS1/CEN4) (32); and a mammalian selectable marker conferring resistance to hygromycin B (hyg B) (33) (Fig. 1A) . The cells transfected with linearized telomere seed were then selected with hyg B. We examined HindIII-digested genomic DNA of each independent hyg B-resistant clone by DNA blotting, using telomere seed probes (probe X and probe Y in Fig. 1A) , and identified the clones with a newly seeded telomere based on the following criteria, as described previously (30) . First, telomeric DNA is sensitive to the pretreatment of genomic DNA with Bal31 exonuclease (Fig. 1B) . Secondly, the size of the telomeric DNA fragment at the particular chromosome terminus (detected by probe X, shown in Fig. 1A) fluctuates because of the heterogeneity of TR length between cells (Fig. 1C and D) . The frequency of TS was defined as the proportion of newly formed telomeres in the total number of integrated telomere seeds (31) . We also confirmed in advance that elements other than the TR in the telomere seed did not affect the frequency of TS (data not shown).
We considered that determination of the cellular characteristics that correlate with the frequency of TS could effectively identify the molecules critical for telomere formation. Barnett et al. (31) previously reported that TS was induced at various frequencies, depending on the cell line examined: from 63% in human teratocarcinoma cells to <2% in human embryonic primary fibroblast. Although the authors did not identify the cellular characteristics closely correlated with the efficiency of telomere formation, they anticipated that heteroploidy and/or telomerase activity would be essential, based on their observation that TS was rarely induced in telomerase-negative primary human fibroblasts (31) . In this study, we first examined the frequency of TS in various human cell lines using the telomere seed carrying a TR of a fixed size (500 bp), in order to determine the cellular characteristics closely correlated with de novo telomere formation (Table 1) .
Contrary to expectation, we found that neither telomerase activity nor ploidy had any direct relevance, by itself, to the frequency of TS. Even though TS was not induced in telomerase-negative primary human fibroblasts, as reported previously, we found that TS was induced efficiently both in telomerase-negative osteogenic carcinoma cells (Saos-2, with a frequency of 56%) and in B lymphoma cells with an almost normal karyotype (BJcl-1R, with a frequency of 88%) ( Table  1) . TS was also observed in another telomerase-negative cell line, at a moderate frequency (VA13/RA2, 41%), further confirming that telomerase is not necessary for telomere formation (Table 1) .
Although telomerase activity was dispensable for de novo telomere formation, the newly seeded TR seemed to be stabilized by the same mechanism as the endogenous TR, during subsequent cell culture (Fig. 1C-H) . The length of the TR at the newly seeded telomere varied among different clones, but was relatively homogeneous within each single clone in telomerase-positive cells (Fig. 1C and D) . A 500 bp TR was elongated to ∼1.1 kb at 24 population doublings (PDs) in HeLa-MJ cells (Fig. 1C) , whereas the same TR was elongated up to 12.5 kb at 24 PDs in HeLa-LT cells (Fig. 1D ) and was elongated further during subsequent culture (data not shown). As HeLa-LT cells had longer TRs (22 kb) at each chromosome (B) Configuration analysis of the integrated telomere seed by DNA blotting. Total DNA was prepared from two independent hyg B-resistant cell lines, established by transfecting linearized pMYAC1 into HeLa-MJ cells. Total DNA (12.5 µg) was digested with Bal31 exonuclease for the periods indicated above, restricted with HindIII and analyzed by DNA blotting, as described in Materials and Methods. When pMYAC1 was seeded as a new telomere (left), probe X detected an outermost heterogeneous telomeric DNA fragment (designated X), sensitive to Bal31 digestion. When pMYAC1 was internally integrated into the chromosome (right), probe X detected a discrete DNA fragment, resistant to Bal31 digestion. In both cases, probe Y detected a proximal DNA fragment (712 bp) (designated Y), resistant to Bal31 digestion. (C-H) DNA blot analysis of hyg B-resistant clones. The hyg B-resistant clones were established by transfecting linearized telomere seeds, with either a 500 bp TR or a 1500 bp TR, into various cell lines, in the following combinations: (C) 500 bp TR into HeLa-MJ cells; (D) 500 bp TR into HeLa-LT cells; (E) 500 bp TR into Saos-2 cells; (F) 500 bp TR into VA13/2RA cells; (G) 1500 bp TR into Saos-2 cells; (H) 1500 bp TR into VA13/RA2 cells. At 24 PDs after transfection, total DNA was prepared and analyzed by DNA blotting as in (B), omitting the Bal31 treatment. The copy number of the telomere seed in a single cell was estimated from the signal intensity of the internal DNA fragment, detected by probe Y. BW78 (a pMYAC1 derivative, lacking the telomere repeat), restricted with HindIII, was used as a copy number standard. T, the clonal cell with a newly formed telomere; N, the clonal cell carrying telomere seed DNA as an integral part of the chromosome.
terminus than HeLa-MJ cells (1.4 kb), the length of the newly seeded TR seemed to be regulated under the same principle as the endogenous TR.
On the other hand, the length of the TR at the chromosome termini generated by seeding a 500 bp TR was quite heterogeneous at 24 PDs, even within each single clone, in telomerase-negative cells (Saos-2 and VA13/2RA cells) ( Fig. 1E and F, respectively). As these heterogeneous signals detected by the distal probe (probe X in Fig. 1A ) satisfied both of the criteria for telomere seeding, a 500 bp TR was clearly sufficient to induce de novo telomere formation in the telomerase-negative cell lines. However, a 500 bp TR would be insufficient to maintain the functional telomere for 24 PDs in the absence of telomerase, considering the rate of TR shortening reported in primary human cells (30-120 bp per PD) (34) and in telomerase-negative immortal human cells (52 bp per PD) (35) . Therefore, we inferred that the high heterogeneity in TR lengths at the newly seeded telomeres was the result of TR stabilization, possibly by elongation independent of telomerase-mediated TR synthesis (20) .
We examined our supposition further by analyzing the structure of the telomere newly seeded with a 1500 bp TR in these telomerase-negative cells ( Fig. 1G and H) . The length of the TR at the newly seeded telomere was relatively homogeneous within each single clone, when the cells were seeded with a 1500 bp TR compared with those in the cells seeded with a 500 bp TR ( Fig. 1E and F) . We estimated the length of the TR associated with the newly seeded telomeres to be 960 bp (Saos-2 cells; Fig. 1G ) and 560 bp (VA13/2RA cells; Fig. 1H ), on average at 24 PDs. These results suggest that a 1500 bp TR was shortened gradually, but was still sufficient to maintain the functional telomere for 24 PDs, without further stabilization. From these data, we also estimated the rates of TR shortening to be 23 bp per PD (Saos-2) and 39 bp per PD (VA13/2RA). These estimates were almost consistent with the rate of TR shortening reported previously in telomerase-negative human cells (34, 35) and with our supposition that a 500 bp TR was consumed in the absence of telomerase, during culture over 24 PDs.
Based on these observations, we concluded that telomere formation proceeds regardless of the mode of telomere stabilization. We found closer correlation between the mortality of the cells and telomere formation: TS was induced by a 500 bp TR to some extent in immortal human cells, regardless of their origins and characteristics, but was not induced at all by a 500 bp TR in primary human fibroblasts (Table 1) .
We then examined the cellular characteristics correlated with TS in immortal cells. The frequency of TS induced by a 500 bp TR varied widely among the immortal cells examined. For example, TS was induced much more frequently in BJcl-1R cells (88%) than in HeLa-LT cells (36%) by a telomere seed carrying a 500 bp TR (Table 1) . Among various characteristics, we found that the telomere length (the length of terminal restriction fragment) of each cell line was inversely correlated to the efficiency of telomere formation in human immortal cells ( Fig. 2A and Table 1 ). In short, TS was induced significantly more frequently in cells carrying short telomeres (HeLa-MJ and BJcl-1R) than in cells carrying long telomeres Table 1 . Relationship between various cellular parameters and the frequency of telomere seeding a The length of TR in the telomere seed. b Incidence of telomere seeding was calculated as the fraction of telomeric events (tel) in examined integration events (int.). c Relative activity defined as the activity in HeLa-MJ cells = 1.0. The activity determined by the stretch PCR method is expressed as the mean ± SD in four independent experiments. Values of <0.05 indicate that activity was below the limits of detection. d The variation in chromosome number is expressed as the mean ± SD in 30 metaphase preparations. 2D and Table 2 ). We examined the statistical correlation between the frequency of TS and the total length of the endogenous TR in single cells and found that these two factors had a significant inverse correlation in immortal human cells (r = -0.968, P < 0.0001) (Fig. 2D, open symbols) . However, as described above, this rule is not applicable to mortal cells. For example, TS was not induced at all by a 500 bp TR in primary human fibroblasts (Fig.  2D, closed triangles) , even though they carried a much shorter TR (2168-2232 kb per cell) than did HeLa-LT cells (3256 kb), in which TS occurred at a significant frequency (36%) (Fig. 2D , open squares). Therefore, TS is not necessarily controlled by the cellular machinery that regulates telomere length.
We also examined the effect of the length of the exogenous TR on the efficiency of telomere formation. The frequency of TS induced in each cell line was proportional to the length of the TR in the telomere seed: a longer TR induced TS more frequently ( Fig. 3A and B) . This rule applies both to telomerase-positive cells (Fig. 3A) and to telomerase-negative cells (Fig. 3B) . Furthermore, a longer TR could compensate for the defect in TS induction by a 500 bp TR in mortal cells. For example, a 2.0 kb TR could induce TS at low frequency (12-13%) in primary human fibroblasts ( Fig. 3C and D, Table 1 ), indicating that immortality is not an absolute requirement for de novo telomere formation. The frequency of TS reached a maximum at ∼85% of the total integration events, even when a telomere seed with a long TR was introduced into HeLa-MJ cells, in which TS was induced readily by a 500 bp TR (Fig. 3A) . The non-telomeric integration of the telomere seed may be caused by a DNA repair mechanism, with illegitimate end-joining followed by non-homologous recombination, which is active in mammalian cells (36) .
In summary, we have identified two major characteristics closely correlated with telomere formation. First, the efficiency of telomere formation depends largely on the immortality of the cells; i.e. TS was induced efficiently in various immortal cells despite their characteristics, whereas it was induced, but only quite inefficiently, in primary cells with limited lifespans (Table 1) . Contrary to previous expectations, telomere formation requires neither telomerase activity, nor the presence of extra chromosomes (Table 1) . Secondly, the efficiency of telomere formation in immortal cells was affected both by the total length of the endogenous TR (Table 2 and Fig.  2D ) and by the total length of the exogenous TR ( Fig. 3A and  B) . In other words, TS was induced more frequently in cells carrying a shorter endogenous TR and by using a longer exogenous TR.
However, this latter observation did not simply mean that telomere formation was regulated by the same mechanism as that regulating telomere length, as described above. Rather, we propose the hypothesis that telomere formation requires some cellular factor(s) to which exogenous and endogenous TRs bind competitively. According to this model, a long endogenous TR would interfere with telomere formation by obstructing the recruitment of the factor by the exogenous TR, whereas a long exogenous TR would stimulate telomere formation by recruiting a sufficient amount of the factor even in factor-deficient cells. Because telomere formation was induced quite inefficiently in mortal cells, we also inferred that Table 2 were plotted and analyzed as described in Materials and Methods. Open symbols, human immortal cell lines; closed triangles, human primary fibroblast; closed circles, HeLa-LT derived cells overexpressing Flag-TRF1. the amount of this hypothetical factor would be small in primary cells with limited lifespans.
Identification of TRF1 as a crucial factor determining the efficiency of telomere formation
Taking account of the deductions described in the previous section, we attempted to identify the hypothetical trans-acting factor required for de novo telomere formation. The primary candidates for this factor are the TR-binding proteins (TRFs). Hanish et al. (6) have suggested that TRF1 might be involved in telomere formation, based on their finding that both TS and TRF1 stringently require the same repetitive DNA sequence (TTAGGG) n . Subsequent to their report, TRF2 (which has a binding specificity similar to that of TRF1) was identified (25, 26) and became another candidate molecule involved in telomere formation. Therefore, we determined the amount of TRF1 and TRF2 in whole cell extracts by quantitative protein blotting (Fig. 4) and examined its relevance to telomere formation. Endogenous TRF1 was detected as a doublet band, with apparent sizes of 61 and 63 kDa (Fig. 4) , as reported previously (27, 37) . The lower band is considered to represent an alternatively spliced form of TRF1, lacking 20 amino acids (27, 37) . Endogenous TRF2 was also detected as a doublet band, with apparent sizes of 65 and 69 kDa (Fig. 4) , as reported previously (26) , but the differences in these two bands have not yet been characterized.
We first found that both TRF1 and TRF2 were present significantly more abundantly in immortal cells than in primary cells (Table 2 ). For example, immortal cells examined in this study contained 16.2-48.9 × 10 3 TRF1 molecules and 23.3-229.8 × 10 3 TRF2 molecules per cell, whereas primary fibroblasts contained 4.7-8.5 × 10 3 TRF1 molecules and 10.0-18.9 × 10 3 TRF2 molecules per cell (Table 2) . Furthermore, quiescent peripheral blood cells contained <2.3 × 10 3 TRF1 molecules and <5.8 × 10 3 TRF2 molecules per cell (Table 2 ). These results indicate that both TRF1 and TRF2 satisfy the first criterion defining the hypothetical factors, that they should be present more abundantly in immortal cells than in primary cells. Next, we examined the statistical correlation between the availability of TRF and the efficiency of telomere formation ( Table 2 , Fig. 5A and B) . The amount of total cellular TRF determined by protein blotting, as described above, does not necessarily reflect the amount of free TRF available to the exogenous TR in the cell. The amount of free TRF was determined by the total amount of TRF in the cell, but was also affected inversely by the total length of the endogenous TR in the cell; i.e. the amount of free TRF will be effectively reduced if TRFs associate with long endogenous TRs. Therefore, we estimated the availability of TRF by expressing the relative amount of TRF per unit length of endogenous TR (indicated as molecules per kb TR) in single cells, as an index of TRF availability (Table 2 ). We then found that the availability of TRF1 correlated more strongly with the frequency of TS (r = 0.989, Figure 2C . Whole cell extract was prepared from cells cultured for 270 PDs after transfection with pJO21 and was analyzed as in (B). P < 0.0001) (Fig. 5A , open symbols) than did the availability of TRF2 (r = 0.869, P = 0.0004) (Fig. 5B, open symbols) .
These observations indicate that TRF1 satisfies the second criterion for the hypothetical trans-acting factor essential for telomere formation. However, we still could not exclude TRF2 as a candidate molecule involved in telomere formation, because the availability of TRF2 correlated significantly with the frequency of TS. So we examined the effect of extra TRF1, expressed by transgenesis, on de novo telomere formation. Because longer exogenous TRs can overcome the inefficiency of telomere formation in TS-reluctant HeLa-LT cells (Fig. 3A) , we anticipated that the total amount of TRF1 recruited to the single telomere seed was a critical factor in creating a new telomere. That is, long TRs induce efficient telomere formation because they can recruit sufficient TRF1 to the chromosome terminus, even in cells deficient in TRF1. We challenged this model by examining whether extra TRF1 could compensate for the requirements of a long exogenous TR in HeLa-LT cells, to induce efficient telomere formation.
We established several independent cell lines derived from HeLa-LT cells, all of which stably expressed a 4-to 7-fold excess of FLAG-tagged TRF1 (27) , at 270 PDs after transfection of the expression vector for this protein (Fig. 4D and Table 2 ). The total amount of TRF2 was not affected significantly by the forced expression of TRF1 (Table 2) . Although these engineered cells carried endogenous telomeres of widely varying lengths (2-20 kb) at 270 PDs (Fig. 2C) , they all contained 76-679 TRF1 molecules per kb TR, which was significantly more abundant than the TRF1 available in the parental HeLa-LT cells (15 TRF1 molecules per kb TR) ( Table 2) . Then, at 270 PDs, we performed a TS assay using the suboptimal 500 bp TR and found that telomere formation was induced in all these cells at a much higher efficiency (73-83%) than in the parental HeLa-LT cells (36%) ( Table 2 ). The frequency of TS did not increase above 85%, even in the presence of abundant TRF1 (Fig. 5A ) and this observation is consistent with our finding that the frequency of TS had a ceiling at 85%, even when sufficiently long exogenous TRs were used for the assay (Fig. 3A) . The correlation that we established between the availability of endogenous TRF1 and the frequency of TS could be relevant to the results obtained in these engineered cells (Fig. 5A , closed circles) (r = 0.991, P < 0.0001).
In contrast, the frequency of TS correlated less significantly with the availability of TRF2 in these cells expressing excess FLAGtagged TRF1 (Fig. 5B, closed circles) (r = 0.618, P = 0.0305). Our conclusion was reinforced by the observation that the frequency of TS induced by a 500 bp TR varied largely among TX3, TX36, VA13/2RA and human primary fibroblast cells (0-83%), although these cells contained similar amounts of available TRF2 (8.6-9.3 molecules per kb TR) ( Table 2 and Fig. 5B) . Furthermore, the frequency of TS did not correlate with the length of the terminal restriction fragment (telomere length). For example, TS was induced by a 500 bp TR at frequencies of 83, 36 and 0% in TX3 cells, in HeLa-LT cells and in TIG3-20PDL cells, respectively, although these cells had terminal restriction fragments of 22, 22 and 12 kb, respectively (Tables 1 and 2 ). These observations indicate that telomere formation correlated with the availability of TRF2 only weakly and was independent of the mechanism regulating telomere length.
From all these results, we conclude that TRF1 is a critical factor required for de novo telomere formation and that the total amount of TRF1 available to the newly created chromosome termini determines the efficiency of telomere formation.
DISCUSSION
In this report, we describe our finding that TRF1 is an essential trans-acting factor for de novo telomere formation, based on experiments using the frequency of TS as an index. TS was initially discovered in yeast (38) and was later demonstrated in mammalian cells (30) . Since then, TS has been investigated as a tool for manipulating mammalian chromosomes (30, (39) (40) (41) , leading to the development of human artificial mini-chromosomes (42, 43) . As well as these practical applications, TS has proved to be a useful tool for the investigation of telomere function in living animal cells, as shown in this and previous studies (6, 31, 44) .
The mechanism by which the TS induces breakage of the chromosome and creates a new telomere at the site of breakage is thought to consist of the following two stages (6, 45) . First, the non-telomeric end of the telomere seed is linked to the broken edge of the chromosome created by double-strand breakage. Next, the linked seed is incorporated into a functional telomere, after elongation by telomerase. However, we propose that the elongation of the TR may not be necessary for telomere formation, for the following reasons. First, telomerase activity is not required for telomere formation, as demonstrated in this study. Secondly, the fate of the novel chromosomal termini to be functional telomeres is fixed within 36 h of transfection of the telomere seed, even though the processivity of TR synthesis from the integrated telomere seed is relatively slow [e.g. estimated to be 130 bp per cell division (31) ]. This conclusion was deduced from our observation that each of the cell clones with seeded telomere contained single copies of the telomere seed integrated into particular sites on the chromosomes. This observation suggested that these cells had monoclonal origins, that had established stable hyg B resistance before, or at the time, we started the selection (36 h after transfection). Thirdly, by using a 2.0 kb exogenous TR, Figure 5 . Correlation between the availability of telomere-binding proteins and the efficiency of telomere formation. The relative amount of TRF1 (A) or TRF2 (B) in each cell line was plotted on the horizontal axis, on a logarithmic scale, and the frequency of telomere seeding induced in these cells was plotted on the vertical axis, on a linear scale. The amount of protein is given as molecules per kb of TR, as shown in Table 2 . Open squares, HeLa-LT cells; closed circles, the cells expressing excess Flag-tagged TRF1; open circles, other cell lines appearing in Table 2 . Statistical analysis of the data was performed as described in Materials and Methods.
TS can be induced even in primary human fibroblasts that lack the mechanism to lengthen the TR (Fig. 3C and D, Table 1 ). Fourthly, a TR as short as 560 bp can stabilize the chromosome termini, at least in VA13/2RA cells, as we have shown in this study (Fig. 1H) . Therefore, it is a reasonable supposition that the induction of TS depends on the probability that the native structure of the exogenous TR was recognized as a functional telomere by the cellular machinery. In other words, the frequency of TS faithfully reflects the mode of interaction between cis-acting exogenous DNA and trans-acting protein factors, both of which are required for efficient telomere formation.
Based on these premises, we examined the correlation between the frequency of TS and the amount of the two TRbinding proteins (TRF1 and TRF2) and identified TRF1 as an essential factor for telomere formation. Although the involvement of TRF1 was strongly suggested from the analysis of natural cell lines (Fig. 5A, open symbols) , conclusive results were obtained from the experiments using cells engineered to express excess TRF1. For example, we established two independent cell lines named TX3 and TX36, which expressed 5-to 7-fold more TRF1, but were otherwise indistinguishable from the parental HeLa-LT cells (Table 2) . We demonstrated that the significant difference in the efficiency of telomere formation between these TRF1-overexpressing cells and the parental HeLa-LT cells could be accounted for solely by the difference in the availability of TRF1, and not by other cellular characteristics (e.g. the availability of TRF2 or the telomere length) ( Table 2 , Fig. 5A and B). Considering these results together, we conclude that the recruitment of sufficient TRF1 to the novel chromosome termini is essential for de novo telomere formation.
TRF1 was the first protein assigned the role of a regulator of telomere length. However, recent studies have revealed that telomere length is regulated by a rather complex mechanism, involving TRF2 (29), TIN2 (46) and hRap1 (47) . In this study, we have identified TRF1 as an essential factor for telomere formation, but this function is independent of telomere length regulation, as discussed above. Furthermore, the amount of TRF1 in the cells did not necessarily correlate with the length of the endogenous telomere (Table 2) . Therefore, our observation reflected some physiological function of TRF1 in vivo not previously recognized.
TRs at the termini of endogenous chromosomes should need to recruit further TRF1 molecules during each round of DNA replication, just as newly synthesized histones are assembled into chromatin during DNA replication in eukaryotic cells (48) . Therefore, it is a reasonable supposition that the availability of TRF1 during DNA replication significantly affects the function of the telomere. Our finding that TRF1 is more abundant in immortal cells than in primary cells with limited lifespans ( Table 2 ), suggests that TRF1 might be involved, at least partly, in the control of the lifespan of mammalian cells and in the establishment of immortality, through the regulation of telomere function. In this context, our observation that the inefficient telomere formation in primary cells can be overcome by long exogenous TRs (Fig. 3C and D, Table 1 ) is meaningful, because it suggests that primary cells need to keep their endogenous TRs above some critical length to recruit sufficient amounts of TRF1 to their telomeres.
Although we have demonstrated the physiological importance of TRF1, the precise mechanism by which TRF1 stabilizes the chromosome termini remains obscure. In this study, we demonstrated that the correlation of protein availability with telomere formation is quite different for TRF1 and TRF2, even though these proteins have the same DNA binding specificity in vitro. We demonstrated that small amounts of TRF2 (9 molecules per kb TR) were sufficient to induce telomere formation at the highest efficiency possible (Fig. 5B) . In contrast, TRF1 must be present much more abundantly (90 molecules per kb TR or more) for efficient telomere formation from a 500 bp exogenous TR (Fig. 5A) . As 1 kb of TR can theoretically bind 40 or more TRF1 molecules (23), our observation suggests that a 500 bp exogenous TR saturated with excess TRF1 is required and/or sufficient for full induction of telomere formation. These findings support, in part, the idea that TRF1 may act as an architectural protein (23) . TRF1 may stabilize the telomere through stimulating t-loop formation (10), or through localization of telomeric DNA at the nuclear matrix, in a condensed structure with TRF1 (49, 50) .
In conclusion, our study provides new perspectives in our understanding of the novel physiological role of TRF1 in mammalian telomere function, distinct from the regulation of telomere length.
MATERIALS AND METHODS
Recombinant DNA
The prototype telomere seed pMYAC1 (9.0 kb) contains a 528 bp synthetic TR, (TTAGGG) 88 , between the NotI and XhoI sites, with the orientation as shown in Figure 1A . pMYAC1 also contains the CEN4/TRP1/ARS1 fragment derived from pYAC2 (32) and hyg B phosphotransferase cDNA (33) , driven by the chicken β-actin promoter. Derivatives of pMYAC1 were prepared by replacing the 528 bp TR with a 0-2000 bp TR in the same orientation. The TRF1 expression vector pGP1 contained FLAG-tagged (DYKDDDD)-hTRF1 chimeric cDNA (27) driven by the cytomegalovirus enhancer/chicken β-actin hybrid promoter. pJO21 was constructed by inserting a selectable gene (RSVNeo), conferring G418 resistance (51) , between the unique SalI and NotI sites of pGP1. Plasmid DNA was purified twice by CsCl gradient centrifugation. Details of construction and the primary structures of these plasmids can be obtained on request.
Cell culture
HeLa-MJ cells (a HeLa-S3-derived cell line) were grown in Eagle's minimal essential medium (MEM), supplemented with 10% fetal calf serum (FCS). GM0131 and Raji (human B lymphoma) cells were grown in RPMI1640 supplemented with 15% FCS. HeLa-LT [previously designated HeLa-I (49)] and BJcl-1R (human B lymphoma) cells were kind gifts from Dr T. de Lange (Rockfeller University) and from Dr S. Imai (Kochi Medical School), respectively. VA13/2RA (SV40-transformed human fibroblast), 293, TIG-3 and TIG-7 (human fetal primary fibroblast) cells were obtained from the Health Science Research Resource Bank (Tokyo, Japan). Human osteogenic sarcoma cells (Saos-2) were obtained from the Riken Cell Bank (Tsukuba, Japan). These cells were cultured as recom-mended by the suppliers. Peripheral blood mononuclear cells were isolated from normal healthy donors, using Lymphoprep (Nycomed, Oslo, Norway). The cell lines expressing FLAGtagged TRF1 (TX series; Table 2 ) were established by transfecting pJO21 into HeLa-LT cells, by a calcium phosphate precipitation method and by selecting with G418 (800 µg/ml) (Life Technologies, Rockville, IL). The cells were screened by indirect immunofluorescent microscopy and by protein blotting, using the anti-Flag monoclonal antibody M2 (EastmanKodak, Rochester, NY). Cells were passaged at 1:32 dilution when they reached 80% confluence. All cells were grown in the presence of streptomycin (100 µg/ml) and penicillin G (100 U/ml), under 5% CO 2 at 37°C.
TS assay
pMYAC1 and its derivatives were linearized by restriction with NotI, followed by dephosphorylation, then purification on agarose gel. Purified linear DNA (0.5-2.5 µg) was transfected into 0.5-1 × 10 7 cells by electroporation (250-370 V, 960 µF), using a Gene Pulser (BioRad, Hercules, CA) on day 0. The cells were divided into 100 dishes (100 mm) or plates (96 well) on day 1. On day 2 (36 h after electroporation), selection with hyg B (300 µg/ml) was initiated. Experimental conditions were adjusted so that 1-5 colonies appeared in each dish or plate. On day 12, 30-60 clones were isolated and cultured further under selective conditions for 24 PDs. Cells (1 × 10 7 ) were incubated in 500 µl of buffer A [200 µg/ml proteinase K, 50 mM ethylenediaminetetraacetic acid (EDTA), 1% sodium dodecyl sulphate (SDS), 100 mM NaCl, 50 mM Tris-HCl pH 7.4] for 2 h at 55°C and overnight at 37°C. Total genomic DNA was then purified by phenol-chloroform extraction and ethanol precipitation. For DNA blotting, genomic DNA (30 µg) was restricted with 150 U of HindIII for 18 h, then 12.5 µg of DNA [quantitated by fluorometry, using Hoechst 33258 (52)] was separated on 0.65% agarose gel in Tris-acetate-EDTA (TAE) buffer. DNA was transferred onto charged nylon membrane (Gene Screen Plus; NEN Life Science, Boston, MA), hybridized at 67°C with a mixture of probes X and Y (Fig. 1A ) labeled with [ 32 P]dCTP by random priming. The frequency of TS was defined as the proportion of newly formed telomeres in the total number of integrated telomere seeds. A Bal31 nuclease assay was performed, as described previously (30) . The hybridization signal was analyzed using a phosphorimager (BAS 2000; Fuji, Tokyo, Japan).
Telomere length analysis
Genomic DNA (20 µg) was digested with HinfI and RsaI, purified and quantified as described above. Restricted DNA was separated on 0.65% agarose gel (for standard electrophoresis) or on 1% agarose gel (for biased sinusoidal field gel electrophoresis) (53) in 0.5× Tris-borate-EDTA (TBE) buffer. DNA blotting and hybridization were performed as described above, except that the terminally labeled oligonucleotide (TTAGGG) 3 was used as a probe, at 50°C. The total length of the TR in single cells was determined from the signal intensity in DNA blotting analysis, using the signal in HeLa-LT cells as the standard (22 kb × 74 chromosomes × 2 = 3256 kb) (54) .
Quantitation of TRFs by protein blotting
Whole cell extract was prepared as described previously (28) . Protein concentration was determined by BCA protein assay (Pierce, Rockford, IL), using bovine serum albumin as standard. Whole cell extract (45 µg) was separated on SDS polyacrylamide gel (8.5%), then transferred to polyvinylidene difluoride (PVDF) membrane (BioRad). The membrane was incubated for 6 h in Tris-buffered saline (TBS) containing 0.2% casein and 0.5% Tween-20, then probed with anti-human TRF1 rabbit serum (1:750) (prepared by immunizing rabbits with the recombinant protein corresponding to the N-terminal acidic domain of TRF1), or with monoclonal anti-TRF2 mouse IgG (1:250) (Upstate Biotechnology, Lake Placid, NY). Signals were then detected with the enhanced chemiluminescence (ECL) system (Amersham-Pharmacia, Little Chalfont, UK) and quantitated with a chemiluminescent image analyzer (LAS1000; Fuji), using recombinant proteins expressed in insect cells as standards for the results shown in Table 2 and in Figure 4A . Signals were also detected with an ECL system and exposure to Hyperfilm-ECL (Amersham-Pharmacia), for the results shown in Figure 4B -D. We used an image analyzer for quantitation of TRFs because this device responds linearly to the light emission from the blot. However, we used X-ray film to present a real image of the protein blot, because the image detected on the film has a higher resolution than that obtained by the image analyzer.
Other assays
Telomerase activity was determined by the modified telomere repeat amplification protocol (TRAP) (55) and by the stretch-PCR method (56) and the results quantitated with phosphorimagery. Metaphase chromosome spreads were prepared from cells treated with 0.1 µg/ml colcemid, as described previously (28) . Thirty metaphase spreads were analyzed for each cell line, using 4′-6-diamidino-2-phenylindole (DAPI) staining. Statistical analysis of Pearson's correlation coefficient was determined using the software package StatView (SAS Institute, Cary, NC). The coefficients between the frequency of TS and the total length of endogenous TR in single cells (Fig. 2D) and those between the frequency of TS and the availability of TRFs (Fig. 5A and B) , were determined and expressed as logarithms.
